Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. Hammitt LL, Dagan R, Yuan Y, Baca Cots M, et al. N Engl J Med 2022;386:837-846.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hammitt LL, Dagan R, Yuan Y, Baca Cots M, et al. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N Engl J Med 2022;386:837-846.
PMID: 35235726